Dr. James E. Boatman, MD

Dr. Boatman practices at Altru Hospital in Grand Forks, North Dakota, part of Altru Health System.

Dr. Boatman's NPI, 1285615724, was assigned on November 10, 2005. Dr. Boatman graduated from Duke University School of Medicine in 1983. Dr. Boatman holds Illinois license 036101606.

Dr. Boatman's primary practice is Altru Hospital, at 1200 S Columbia Rd, Grand Forks, ND 58201 in Grand Forks County. The practice phone is (701) 780-5000.

Dr. Boatman's primary practice is Altru Hospital in Grand Forks, North Dakota, part of Altru Health System. Dr. Boatman is also affiliated with Saint Alphonsus Regional Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Boatman to 4 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boatman practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Boatman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Boatman's licenses on file in 4 states: Illinois, Indiana, Montana and Wisconsin.

CMS data shows 533 Medicare services from Dr. Boatman across 16 procedure codes in 2024, for 306 Medicare patients. Medicare paid $35,589 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 306 Medicare patients who saw Dr. Boatman in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boatman's median patient age at 75, with 50% women.

In 2024, Dr. Boatman wrote 101 Medicare Part D claims for 22 patients. 87% of them were for generic drugs. CMS names the drug for 84 of them, across 5 drugs with 11 or more claims each, at $6,029 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

Dr. Boatman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 37 procedures of coronary angioplasty and stenting by Dr. Boatman, more than 73% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 291 general payments to Dr. Boatman from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 86% of the total. Boston Scientific Corporation paid the most, $2,739.

Dr. Boatman graduated from Duke University School of Medicine in 1983.